Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study (Q68232226)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 July 1992

Language	Label	Description	Also known as
English	Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study	scientific article published on 01 July 1992

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642687%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study. The LARS Investigators (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642687%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter study (English)

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

familial hypercholesterolemia

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642687

20 October 2022

Cardiology and cardiovascular medicine

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

author name string

R. Tatami

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642687

20 October 2022

N. Inoue

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642687

20 October 2022

H. Itoh

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642687

20 October 2022

B. Kishino

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642687

20 October 2022

N. Koga

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642687

20 October 2022

Y. Nakashima

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642687

20 October 2022

T. Nishide

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642687

20 October 2022

K. Okamura

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642687

20 October 2022

Y. Saito

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642687

20 October 2022

T. Teramoto

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1642687

20 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1642687

20 October 2022

publication date

1 July 1992

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642687%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

full work available at URL

https://api.elsevier.com/content/article/PII:002191509290170L?httpAccept=text/xml

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

https://api.elsevier.com/content/article/PII:002191509290170L?httpAccept=text/plain

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642687%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

95

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642687%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642687%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1-13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642687%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

4

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

6

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis. Characterization and experimental use in hypercholesterolemic rabbits

8

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia

9

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis)

10

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Treatment of hypercholesterolemia by chemical adsorption of lipoproteins

11

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Evaluation of selective LDL-removal in the treatment of familial hypercholesterolemia: double membrane filtration and adsorption system

12

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Plasmapheresis in familial hypercholesterolemia

14

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Effects on coronary atherosclerosis of long-term treatment of familial hypercholesterolemia by LDL-apheresis

17

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Regression of coronary sclerosis in familial hypercholesterolemia IIa by specific LDL apheresis

18

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Factors linking cholesterol to atherosclerotic plaques

25

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Plasma exchange in the management of homozygous familial hypercholesterolaemia

27

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Plasma exchange for hypercholesterolaemia

28

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Plasma exchange and low density lipoprotein apheresis in Watanabe heritable hyperlipidemic rabbits

29

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Cholesterol flux in cholesterol ester-loaded macrophages in an in vitro perfusion system

30

1 reference

10.1016/0021-9150(92)90170-L

https://api.crossref.org/works/10.1016/0021-9150(92)90170-L

20 October 2022

Identifiers

10.1016/0021-9150(92)90170-L

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642687%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1642687%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68232226&oldid=1754754920"